COPD multimorbidity management: A person-centred clinical approach to the multimorbid patient with COPD
COPD Multimorbidity Management: A Patient-Centred Approach
Most patients with a chronic disease are multimorbid. This is particularly important in patients with chronic obstructive pulmonary disease (COPD), who on average have five other identified comorbidities that independently impact their health and increase their mortality risk
Identifying Key Comorbidities in COPD
Using a modified Delphi method, we selected the 20 most important diseases associated with COPD and clustered them into five domains: mental, respiratory, cardiovascular, metabolic and multiple organs loss of tissue.
We then developed a systematic approach to characterise the impact and clinical presentation of individual diseases within each cluster.
Developing Tools for Clinical Management
Given the absence of integrated guidelines to treat multimorbid patients, we reviewed and selected individual disease guidelines or recommendations that can be accessed for specific information related to the management of each disease.
In addition, we built a multimorbidity ‘Health Dashboard’ that, completed by the patient or health practitioner, can help identify the presence and severity of comorbid diseases.
Towards Better Outcomes in Multimorbid COPD Patients
By using a practical comprehensive approach, it is possible to identify and characterise important comorbid diseases in patients with COPD, and to implement management tools that should help improve their outcome.
This expert consensus commentary summarises patient-centred recommendations to manage comorbidities in COPD patients, aiming to improve quality-of-life and reduce disease burden through a holistic approach.
Need for Future Research
Prospective pragmatic trials comparing such an approach with usual care for multimorbid patients with COPD including long-term follow-up are urgently needed.
Authors
Bartolome R. Celli, Leonardo M. Fabbri, Abebaw M. Yohannes, Nathaniel M. Hawkins, Gerard J. Criner, Jessica Bon, Marc Humbert, Christine R. Jenkins, Leonardo Pantoni, Alberto Papi, Jennifer K. Quint, Sanjay Sethi, Daiana Stolz, Alvar Agusti, Don D. Sin
Read more details at
Fecha de publicación
12 August 2025
Categorías asociadas al artículo
Noticias relacionadas
Towards early detection and disease interception of COPD across the lifespan
Discover how early-life genetic and environmental factors contribute to COPD and how emerging strategies aim to detect and intercept the disease early. Review from the European Respiratory Review, July 2025
Sputum metagenomics in bronchiectasis reveals pan-European variation: an EMBARC-BRIDGE study
Sputum metagenomics reveals pan-European variation in microbial and resistome profiles in bronchiectasis: an EMBARC-BRIDGE study.
Metabolomic Plasma Profile of Chronic Obstructive Pulmonary Disease Patients
This study identifies a metabolic signature of COPD patients, involving fatty acids, amino acid and carbohydrate metabolites, using LC-MS plasma profiling.
Alteraciones espirométricas y sus factores de riesgo en la población joven ambulatoria
Un estudio reciente en Osona (Cataluña) refleja que 20,7% de jóvenes presenta alteraciones espirométricas. También revela síntomas y factores de riesgo en la población joven ambulatoria.
A Pilot Study on Proteomic Predictors of Mortality in Stable COPD
Proteomic Predictors of Mortality in Stable COPD is the objective of this pilot study. It searchs to identify proteomic markers and specific multiprotein signatures that could be useful in predicting long-term mortality
Climate Change & COPD: A GOLD Science Committee Review
Climate change and COPD are linked through extreme temperature, wildfire smoke, dust storms and allergen exposure, which pose major health threats.
Imagen desarrollada con IA